• JD Health annual report for year ended Dec. 31, 2025 flagged continued expansion of AI-enabled healthcare services across consultation, diagnosis, and pharmaceutical fulfillment.
• Online hospital rolled out 24/7 free consultations via AI agent “Dr. Da Wei,” reaching hundreds of millions of interactions with 98% user satisfaction as of Dec. 31, 2025.
• Pharmaceutical retail strategy emphasized faster access to innovation, with more than 100 new drug launches during 2025.
• On-demand healthcare retail scaled online medical insurance payment services to 29 cities, supported by more than 300 self-operated pharmacies by end-2025.
• Management outlined 2026 focus on supply chain efficiency, direct sales execution, and faster AI deployment to broaden healthcare service offerings.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JD Health International Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260424-12121182), on April 24, 2026, and is solely responsible for the information contained therein.